Taisho Pharmaceutical Holdings Financials

Taisho Pharmaceutical Stock Summary

Taisho Pharmaceutical competes with Shionogi, Pacira BioSciences,, Haleon Plc, Dr Reddys, and Emergent Biosolutions. Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people.

Taisho Pharmaceutical Key Financial Ratios

Taisho Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Taisho Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Taisho Pharmaceutical over time and compare it to other companies across industries.

Taisho Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Taisho Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Taisho Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Taisho Pharmaceutical competition to find correlations between indicators driving Taisho Pharmaceutical's intrinsic value. More Info.Taisho Pharmaceutical Holdings is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.53  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Taisho Pharmaceutical Holdings is roughly  1.89 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Taisho Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Taisho Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.